Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14
Review
New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
13,405 | Dovepress* | 10,885+ | 1,774 | 12,659 | |
PubMed Central* | 2,520 | 844 | 3,364 | ||
Totals | 13,405 | 2,618 | 16,023 | ||
*Since 23 April 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 1 | 0 | 0 | 1 | 2 |
View citations on PubMed Central and Google Scholar